Webinar | MFN After the Midterms: Escalation, De-escalation, or a New Direction?

On November 6, 2026, Executive Insight and Jayson Slotnik, leading US health policy expert and founder of Health Policy Strategies, hosted a webinar exploring the evolving Most Favored Nation (MFN) policy landscape following the US midterm elections.

Webinar: MFN After the Midterms: Escalation, De-escalation, or a New Direction?

During this 60-minute session, we discussed:

  • What the US midterm election results mean for the future of MFN policy
  • Emerging US policy scenarios and their potential implications for markets outside the US
  • The strategic implications for pharmaceutical companies and how they can prepare for what comes next

The discussion focused on helping global and regional pharmaceutical leaders navigate policy uncertainty, anticipate potential business implications, and develop strategic responses as the Trump Administration enters the second half of its term.

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK